微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -2.65% | -221.56% | 41.24% | 118/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | -4.51% | -905.36% | 90.84% | 127/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -49.26% | -1316.3% | -1742% | 129/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 3% | -32.43% | 37.61% | 71/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 2.18% | -41.71% | 289.29% | 67/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.56% | -60.56% | -86.17% | 87/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 4.05% | -44.14% | -8.78% | 68/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 4.44% | -28.04% | 18.72% | 63/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 3.74% | 4.18% | 163.38% | 55/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.42% | 25.66% | -80.41% | 62/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 7.25% | 21.44% | 17.5% | 58/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 6.17% | 54.25% | 71.87% | 55/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 3.59% | 39.69% | 217.7% | 64/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.13% | 17.71% | -81.07% | 81/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 5.97% | 22.09% | 49.25% | 91/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 4% | 18.69% | 55.64% | 92/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.57% | 4.9% | 167.71% | 90/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.96% | 26.32% | -80.37% | 93/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 4.89% | 64.65% | 45.1% | 110/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 3.37% | 188.03% | 37.55% | 99/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 2.45% | 488.89% | 222.37% | 104/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 0.76% | 162.3% | -74.41% | 92/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 2.97% | -36.4% | 153.85% | 114/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 1.17% | -64.33% | 285.71% | 82/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | -0.63% | -124.32% | 48.36% | 107/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | -1.22% | -238.64% | -126.12% | 74/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 4.67% | -25.28% | 42.38% | 99/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 3.28% | -16.11% | 26.64% | 55/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 2.59% | -15.08% | 194.32% | 57/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.88% | 12.82% | -85.92% | 45/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 6.25% | -8.63% | 59.85% | 85/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 3.91% | 6.25% | 28.2% | 46/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 3.05% | -13.6% | 291.03% | 42/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.78% | -54.91% | -88.6% | 44/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 6.84% | -15.76% | 85.87% | 75/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 3.68% | -35.66% | 4.25% | 40/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 3.53% | -27.07% | 104.05% | 42/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 1.73% | -4.95% | -78.69% | 31/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 8.12% | -12.97% | 41.96% | 61/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 5.72% | -10.9% | 18.18% | 27/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 4.84% | -21.3% | 165.93% | 28/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 1.82% | -32.34% | -80.49% | 19/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |